Related Experiment Video
Updated: Jan 10, 2026

Introducing Point Mutations into Human Pluripotent Stem Cells Using Seamless Genome Editing
Published on: May 10, 2020
CRISPR/Cas9-mediated editing of MIC13 in human induced pluripotent stem cells: A model for mitochondrial
Haribaskar Ramachandran1, Alexander Becker2, Jochen Dobner1
1Genome Engineering and Model Development, IUF-Leibniz Research Institute for Environmental Medicine, Düsseldorf, Germany.
Abstract:
MIC13 is essential for cristae formation and functions as a key component of the large mitochondrial multi subunit MICOS complex. Mutations in MIC13 causes severe mitochondrial disease called mitochondrial hepato-encephalopathy. In this study, we describe the generation of a human induced pluripotent stem cell (iPSC) line carrying a patient-specific MIC13 mutation, introduced using a CRISPR/Cas knock-in approach. The resulting iPSC line will provide a valuable model to study the pediatric severe mitochondrial disease and to determine the pathological mechanisms as well as to facilitate the identification of potential therapeutic targets in the future.
More Related Videos
Related Concept Videos
CRISPR/Cas9 Genome Editing
CRISPR

